Bayer Plans to Avoid Patent Cliff
Bayer’s pharmaceutical division is doing well. The company says it has the best portfolio ever. But this success brings a lot of risk.
Bayer is seeing good results from its drugs. The company’s leaders believe this is the strongest portfolio they have ever had. They expect more growth because of this. However, the drugs are losing patent protection. This means other companies can make similar drugs. Bayer faces challenges because of this change.
Summarized from the sources above. Read the originals for the full story.
Highlights
Bayer Pharma Performance
Bayer’s pharmaceutical division is doing well and avoiding problems with expiring drugs.
Strongest Portfolio Ever
The company’s leadership says this is the strongest portfolio in its history.
High Expectations Created
This good performance is leading to high expectations for the company.
Significant Risk Exists
The company faces significant risk because of this growth.
Navigating Patent Expirations
Bayer is successfully avoiding problems with drugs losing their patents.